295 related articles for article (PubMed ID: 35804480)
1. Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches.
Lazar S; Kahlenberg JM
Annu Rev Med; 2023 Jan; 74():339-352. PubMed ID: 35804480
[TBL] [Abstract][Full Text] [Related]
2. Interferons in Systemic Lupus Erythematosus.
Sirobhushanam S; Lazar S; Kahlenberg JM
Rheum Dis Clin North Am; 2021 Aug; 47(3):297-315. PubMed ID: 34215365
[TBL] [Abstract][Full Text] [Related]
3. The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases.
Ramaswamy M; Tummala R; Streicher K; Nogueira da Costa A; Brohawn PZ
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681945
[TBL] [Abstract][Full Text] [Related]
4. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
Chyuan IT; Tzeng HT; Chen JY
Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon signature in systemic lupus erythematosus.
Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies.
Infante B; Mercuri S; Dello Strologo A; Franzin R; Catalano V; Troise D; Cataldo E; Pontrelli P; Alfieri C; Binda V; Frontini G; Netti GS; Ranieri E; Gesualdo L; Castellano G; Stallone G
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555640
[TBL] [Abstract][Full Text] [Related]
7. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus.
Davis LS; Hutcheson J; Mohan C
J Interferon Cytokine Res; 2011 Oct; 31(10):781-9. PubMed ID: 21787222
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets.
Crow MK
Ann Rheum Dis; 2023 Aug; 82(8):999-1014. PubMed ID: 36792346
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications.
Liu J; Zhang X; Cao X
J Autoimmun; 2022 Oct; 132():102856. PubMed ID: 35773101
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus (SLE): emerging therapeutic targets.
Mathias LM; Stohl W
Expert Opin Ther Targets; 2020 Dec; 24(12):1283-1302. PubMed ID: 33034541
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus: Diagnosis and clinical management.
Fava A; Petri M
J Autoimmun; 2019 Jan; 96():1-13. PubMed ID: 30448290
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
14. Immunological pathogenesis and treatment of systemic lupus erythematosus.
Pan L; Lu MP; Wang JH; Xu M; Yang SR
World J Pediatr; 2020 Feb; 16(1):19-30. PubMed ID: 30796732
[TBL] [Abstract][Full Text] [Related]
15. The innate immune system in human systemic lupus erythematosus.
Weidenbusch M; Kulkarni OP; Anders HJ
Clin Sci (Lond); 2017 Apr; 131(8):625-634. PubMed ID: 28351959
[TBL] [Abstract][Full Text] [Related]
16. Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy.
Idborg H; Oke V
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768756
[TBL] [Abstract][Full Text] [Related]
17. Type I interferon in systemic lupus erythematosus.
Crow MK
Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Responses and Therapeutic Interventions for Systemic Lupus Erythematosus: A Comprehensive Review.
Pandey SP; Bhaskar R; Han SS; Narayanan KB
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):499-518. PubMed ID: 37718519
[TBL] [Abstract][Full Text] [Related]
19. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
[TBL] [Abstract][Full Text] [Related]
20. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
Tumurkhuu G; Montano E; Jefferies C
Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
